Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis
Background and aims: Nonalcoholic steatohepatitis (NASH) has become one of the major causes of cirrhosis and liver failure. However, there are currently no approved medications for managing NASH. Our study was designed to assess the effects of ginkgetin on NASH and the involved mechanisms.Methods: W...
Main Authors: | Chaoyang Wang, Yaowei Bai, Tongqiang Li, Jiacheng Liu, Yingliang Wang, Shuguang Ju, Wei Yao, Bin Xiong, Guofeng Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1267445/full |
Similar Items
-
Angiogenic effects of leptin in patients with nonalcoholic steatohepatitis
by: Gaafar Nagah, et al.
Published: (2005-01-01) -
Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity
by: Joseph L. Jilek, et al.
Published: (2021-12-01) -
Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome
by: Martha D. Gay, et al.
Published: (2022-02-01) -
A simple method for inducing nonalcoholic steatohepatitis with fibrosis
by: Leyla Yahaghi, et al.
Published: (2019-12-01) -
Neuroprotective Potential of Biflavone Ginkgetin: A Review
by: İ. İrem Tatlı Çankaya, et al.
Published: (2023-02-01)